PenderFund Capital Management Ltd.

Position in MRVI — Maravai Lifesciences Holdings, Inc.

CIK 1706164 VANCOUVER, A1

Position in MRVI

as of Jun 30, 2026 · filed Aug 17, 2026 Compact

Position Value

$1,279,200

+$699,050 QoQ

Shares Held

205,000

0.0% QoQ

Ownership

0.079%

of shares outstanding

% of Portfolio

0.63%

of 13F equity value

Holder Rank

#59

of 177 holders

Holding Since

Jun 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PenderFund Capital Management Ltd. holds $1,699,256 across 5 Biotechnology names. MRVI ranks #1 (75.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRVI	Maravai Lifesciences Holdings, Inc. This page	205,000	$1,279,200
2	XENE	Xenon Pharmaceuticals Inc.	6,850	$413,466
3	RNA	Atrium Therapeutics, Inc.	490	$6,590
4			17,800	$0
5			5,200	$0

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,279,200	205,000	0.0%	Shares	Sole	2026-08-17
2026-03-31	$580,150	205,000	-7.0%	Shares	Sole	2026-05-15
2025-12-31	$716,625	220,500	-47.5%	Shares	Sole	2026-02-17
2025-09-30	$1,204,989	419,857	-51.8%	Shares	Sole	2025-11-14
2025-06-30	$2,097,182	870,200	+5.3%	Shares	Sole	2025-08-14
2025-03-31	$1,826,123	826,300	+42.4%	Shares	Sole	2025-08-14
2024-12-31	$3,162,635	580,300	+48258.3%	Shares	Sole	2025-02-14
2022-09-30	$30,636	1,200	0.0%	Shares	Sole	2022-11-14
2022-06-30	$34,092	1,200	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.